July 18th, 2017
Forefront is the complimentary magazine of the Mayo Clinic Cancer Center. Published in print and online magazine editions annually and in email and online newsletter editions quarterly, Forefront highlights Mayo Clinic’s cutting-edge cancer research and the latest Cancer Center news. View the online edition. View the email newsletter. Subscribe.
June 28th, 2017
With colon cancer, some earlier stage patients fare worse than some later stage patients, who usually benefit most from chemotherapy. But a research team at Mayo Clinic has discovered that a simple blood test could help determine which patients are at a higher risk and therefore could benefit from therapy. The researchers also found many patients who could benefit from the test likely aren’t receiving it.
June 21st, 2017
Mayo Clinic’s aging research was among the featured topics at the 10th annual World Science Festival in New York earlier this month. James Kirkland, M.D., Ph.D., director of the Robert and Arlene Kogod Center on Aging, shared details about cell senescence breakthroughs and next steps in the field during a 90-minute session called “Engineering Immortality?” […]
June 19th, 2017
A growing number of Americans are expected to develop atrial fibrillation, a common heart condition characterized by an irregular and rapid heart rate. But almost 1 in 6 of the millions of Americans on new blood-thinning medications for a-fib may not be getting the right dose, Mayo Clinic research finds.
June 1st, 2017
The Rochester Epidemiology Project has added dental records to its database of linked medical records, making it more valuable as a medical research resource. The Rochester Epidemiology Project is a collaboration of medical and dental care providers in Minnesota and Wisconsin. With patient agreement, the organizations link medical, dental, surgical procedures, prescriptions, and other health […]
May 25th, 2017
HER WAY BACK North Dakota woman on leading edge of epilepsy research with implanted device For the 50 million children and adults worldwide who live with epilepsy, the brain’s electrical circuitry shorts out spontaneously. As many as one-third of patients, 1 million in the U.S. alone, find no relief with existing medications and must explore […]
April 25th, 2017
When nerve cells in the brain and the spinal cord stop working normally there is a noticeable change in muscle movement and activity. Motor neurons work with the brain to control muscle movement such as gripping and walking. These activities become increasingly difficult with the onset of amyotrophic lateral sclerosis (ALS) also known as Lou […]
August 3rd, 2016
By Bob Nellis
The core group of Mayo Clinic researchers that moved their lab to the base camp at Mount Everest to study heart disease and aging are at it again, this time in Africa. Along with a party of nearly 35, they will be climbing Mt. Kilimanjaro, obtaining scientific data from the climbers along the way. Led by […]
May 31st, 2016
By Bob Nellis
On May 17, 2016, the U.S. Food and Drug Administration granted accelerated approval to nivolumab (Opdivo®) for the treatment of patients with classical Hodgkin lymphoma (cHL) that has relapsed or progressed after autologous hematopoietic stem cell transplantation. Nivolumab also received a breakthrough therapy designation for the treatment of relapsed or refractory cHL after failure of […]
January 19th, 2016
Aging: It’s a topic that impacts each and every one of us. It’s the single greatest risk factor for most chronic diseases, which account for the majority of morbidity and health care expenditures in developed nations. In a recently released book, “Aging: The Longevity Dividend,” experts in the field explore the topic and concurrent research […]